The Healthcare Triangle Blog

Through and beyond the global pandemic, ensuring regulatory compliance and data security is critical for leaders across the accelerating healthcare and life sciences industries. Organizations dealing with a patient’s personal health information must meet the required regulations for protecting and securing the information to avoid data breaches. Working with a HITRUST certified vendor can assure partners and patients that their data is maintained with the highest level of security.

Leading pharmaceutical companies and life sciences organizations around the globe are moving fast to revolutionize the way they do business. With dramatically increased spending and investment in digital transformation initiatives, these firms are focused on accelerating business growth and efficiency while minimizing costs.

Recently, researchers unveiled a technique for using artificial intelligence (AI) to diagnose COVID-19 from X-rays in mere minutes, compared with waiting hours for the results of a PCR test. It’s yet another example of the in-roads AI and its offspring, machine language (ML) and natural language processing (NLP), are making in medicine.

In October 2021, a ransomware attack compromised the insurance, diagnosis, treatment and other protected health information (PHI) of some 400,000 patients of a women’s health clinic in Los Angeles. The same month, hackers broke into the computer systems of a Florida-based healthcare network, compromising the PHI of some 1.3 million members.

Creating end-to-end visibility in supply chain management and maintaining prescription drug traceability and integrity holds utmost importance in the pharmaceutical industry, which is currently accelerated by the mandatory compliance of the Drug Supply Chain Security Act (DSCSA).

By 2025, experts expect the healthcare cloud computing market to reach $64.7 billion as organizations seek to improve operational and clinical efficiencies. The business case for moving to the cloud is clear. To achieve digital transformation—which involves automation—the cloud is the best place to implement artificial intelligence, machine learning, robotic process automation, and more.

More than 60% of healthcare IT leaders say a key part of their organization’s digital transformation consists of transitioning their business operations to the cloud, according to a recent survey by Healthcare Triangle (HCTI).

The business case for moving healthcare operations to the cloud is compelling. As artificial intelligence, machine learning, robotic process automation, and other innovations take hold in healthcare, the cloud offers virtually unlimited capacity to leverage these resource-intensive applications.

Epic’s Community Connect program enables large healthcare systems with Epic EHRs to “share” their systems with independent and small-group practices. But there’s a lot to consider in selecting a host.

Pharma and life sciences companies are placing big bets on digital innovation. Research by Gartner shows 85% to 90% of these companies expect digital transformation to advance performance, while 75% design digital technology platform teams with revenue-generating programs in mind.

As the threat and cost of ransomware attacks in life sciences rises, organizations face intense pressure to embed new controls that protect the integrity of their data, including patient data from clinical trials, electronic health records, physicians notes, etc.

Data analytics and data science are the buzzwords of the moment for life sciences organizations, and for good reason.

Six out of 10 healthcare organizations are adopting a hybrid approach to cloud adoption, a recent CHIME survey of healthcare IT executives found, while 10% rely on public cloud services and 11% use a private-cloud approach. Yet 47% say it’s too early to tell whether their investment is providing value—a finding that could point to the value of a managed services approach.

There is a burning need for blockchain in pharma. Today, large pharmaceutical companies are betting on blockchain to help accelerate drug development and discovery, better understand how certain chemicals affect specific demographics, and improve their supply chain, all by securely sharing data in real time.

We’re in an era where pharmaceutical companies can predict whether an individual will switch to a new prescription drug based on data captured from that person’s Twitter feed. But many life sciences organizations struggle to rapidly analyze the treasure trove of data they now have access to—and it’s holding them back from innovation.

From genetic breakthroughs that could transform treatment for complex conditions to new biosensor technologies that could revolutionize diagnostics, new innovations have led to a radical reimagining of the future of life sciences—and cloud-based platforms are at the center of this transformation.

Seven out of 10 physicians have used the same electronic health record (EHR) for more than five years, a Medical Economics survey found. Yet one-third of physicians still struggle with EHR usability: 38% want a system that is easier to use, and 33% want customization options.

The life sciences and the pharmaceutical industry have always been in the throes of change—be it a radical medical breakthrough or a unique product and service innovation driving the wave of digital transformation.